![]() |
|
![]() |
||||
Thread | Thread Starter | Forum | Replies | Last Post |
PubMed: Exome sequencing: a transformative technology. | Newsbot! | Literature Watch | 0 | 09-24-2011 05:21 AM |
Confirmation sequencing technology | gendxdoc | General | 7 | 08-05-2011 05:18 AM |
Tech Summary: Animated video explaining Helicos tSMS Next-gen Technology | apfejes | Helicos / Direct Genomics | 8 | 06-17-2011 10:10 AM |
Question and Answer Format: http://I.SEQanswers.com | ECO | Site Announcements | 33 | 10-05-2010 06:07 AM |
Amplicon sequencing using Titanium technology | sacha | 454 Pyrosequencing | 2 | 04-23-2009 05:08 AM |
![]() |
|
Thread Tools |
![]() |
#1 |
--Site Admin--
Location: SF Bay Area, CA, USA Join Date: Oct 2007
Posts: 1,358
|
![]()
...what small study would you do?
This is intended as a bit of fantasy, but a serious question, as I've often considered this question: If you could do one small set of focused samples what would they be and what platform would you use to answer the question? Cost/labor/your ability to analyze the data is not to be considered...we're talking pure scientific curiousity. Let's limit it to say one run on a GA/SOLiD, or 2-3 runs on 454, or a combination of short/long reads. But no more than 8-16 samples. Moon rocks? Environmental mining? The fauna scraped off your windshield after a cross country drive? Swabs from a subway seat? |
![]() |
![]() |
![]() |
#2 |
Member
Location: Wageningen, the Netherlands Join Date: Jan 2008
Posts: 31
|
![]()
N timepoints for 3 patients from birth to death. Patients are triplets (twins+1) . The first two would be raised in the same environment, the third would be separated at birth. Sequence the epigenome. No clear platform preference.
No triplets were harmed in the making of this fantasy. Last edited by cariaso; 05-07-2008 at 04:01 PM. |
![]() |
![]() |
![]() |
#3 |
Senior Member
Location: Vancouver, Canada Join Date: Feb 2008
Posts: 236
|
![]()
I like cariaso's study, though I'd also do gene expression studies:
I'd take N drug therapies, and test the whole transcriptome shotgun expression on each of M cell types, on X people, where N, N and X are impossibly large numbers. And, of course, each of the X people would also have a complete genome reference assembled. You'd be able to figure out what parts of the genome cause drug interactions (successful, no effect or adverse side effect) if M,N and X were large enough. For people who develop resistance, ie. cancer drugs no longer work, I'd also WTSS those tissues before and after resistance occurs to identify mechanisms. What fun!
__________________
The more you know, the more you know you don't know. —Aristotle |
![]() |
![]() |
![]() |
Thread Tools | |
|
|